Tag: science
-
The embodied-AI commercial landscape — a record funding boom coexists with almost no deployed autonomous worker; the bottleneck is the outcome layer (autonomy, robot data, reliability), not the chassis
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All valuation, funding and market-size figures are attributed to the company announcement, trade press or bank projection as noted inline; private post-money rounds are not audited or market-clearing values, “in-talks” rounds are not…
-
Embodied AI, Part 4 — the hardware is maturing and the demos and pilots are real, but the true ceiling is the deployment layer: lights-out autonomous reliability and labor-replacement unit economics
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All deployment, pilot, uptime and cost figures are attributed to their source, and separated into three tiers: peer-reviewed / primary reporting (IEEE Spectrum), company press release or company page (company claim), and secondary…
-
Embodied AI Part 3 — the data bottleneck: robot foundation models have no internet-scale corpus, and teleop, sim and human video have not closed Goldberg’s 100,000-year gap
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All dataset sizes, teleoperation costs, simulation-fidelity claims and synthetic-data figures are attributed to the relevant arXiv paper, journal, NVIDIA blog or company announcement. Peer-reviewed sources (Science Robotics, arXiv academic work), company/vendor claims (NVIDIA,…
-
Robot foundation models / VLA — the “ChatGPT moment for robotics” claim versus what the benchmarks actually measure
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. Every generalization figure below is attributed to the model’s arXiv paper or to a DeepMind / Nvidia / Physical Intelligence / Figure announcement; peer-reviewed and arXiv results are separated from company demos and…
-
Humanoid hardware platforms — the chassis, actuators and hands are maturing fast and are no longer the binding constraint, but a good spec sheet is not autonomous capability, and most deployment demos are teleoperated, pre-trained or cherry-picked
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. Every degree-of-freedom (DoF), cost, unit-count, runtime and payload figure is attributed to the manufacturer spec, company statement, teleoperated demo or trade-press aggregator that reported it, and first-party specs are separated from company claims.…
-
The embodied-AI landscape — humanoid hardware is maturing and is no longer the bottleneck; the binding constraint is autonomous cross-task generalization, real-robot data scarcity, sim-to-real and reliability (impressive demo ≠ deployable autonomous worker)
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All generalization figures, deployment counts and valuations are attributed to the source. VLA generalization numbers (RT-2 ~3x, Gemini Robotics ~60/80%, RT-2-X ~3x) are all within-benchmark / in-protocol success rates, not real-world autonomous task…
-
The commercial landscape of AI protein design — funding is at the $10^9 scale, but the number of approved de novo AI-designed protein drugs is zero
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice, not medical advice. All funding, valuation and milestone totals are attributed to each company’s press releases or media reports; many details cannot be independently verified and are marked as such. Vendor blog/preprint performance…
-
The space economy’s paradox — launch costs collapsed, but only one player won: SpaceX’s single vertically-integrated capture vs a thin downstream, and the series wrap-up
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. All revenue, valuation and market-size figures are attributed to the filing, announcement or trade-press aggregate they come from; company claims, agency data, analyst estimates and press reports are separated inline. Marketed $/kg is…
-
The bottleneck moved — cost-to-orbit collapsed, but the real ceilings are unit economics, orbital sustainability, spectrum and demand
Evidence-first notes on bioscience and deep tech, at the edge of the lab and the market. Information only — not investment advice. Public-company financials are attributed to SEC filings (primary); Starlink segment economics are attributed to reporting on a private company and to analyst estimates (pending post-IPO audited financials). All orbital-environment, debris and spectrum figures…
